期刊论文详细信息
Health and Quality of Life Outcomes
Predictors of health-related quality of life in patients with irritable bowel syndrome. A cross-sectional study in Norway
Per G. Farup2  Per Olav Vandvik1  Vilde Lehne Michalsen2 
[1] Department of Medicine, Innlandet Hospital Trust, Gjøvik, N-2819, Norway;Unit for Applied Clinical Research, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, N-7491, Norway
关键词: Therapy;    Quality of life;    Irritable bowel syndrome;    Comorbidity;   
Others  :  1224735
DOI  :  10.1186/s12955-015-0311-8
 received in 2015-02-26, accepted in 2015-07-21,  发布年份 2015
PDF
【 摘 要 】

Background

Reduced quality of life (QoL) is often the main problem for patients with irritable bowel syndrome (IBS). This study aimed at finding predictors of reduced physical and mental quality of life (QoL) accessible for intervention.

Methods

Consecutive patients with IBS (according to the Rome II criteria) visiting a general practitioner were included in a prospective cohort study and followed up for 6−9 months. At the last visit, information about sociodemographic characteristics, abdominal complaints, QoL and a range of physical and mental comorbidities were collected. Physical and mental QoL were measured with the generic QoL instrument Short Form-12 Physical Component Score (SF-12 PCS) and Short Form-12 Mental Component Score (SF-12 MCS) respectively. The normal scores are 50. This cross-sectional study used data from the last visit.

Results

Out of 208 patients included in the cohort study, 149 (female/male: 105/44) with a mean age of 52 years (SD 15.3) were available for the analyses. Physical and mental QoL were reduced, the mean SF-12 PCS and SF-12 MCS scores were 38.4 (SD 11.9) and 45.0 (SD 11.3) respectively. The main independent predictors of low SF-12 PCS and SF-12 MCS were subjective health complaints and organic diseases, and affective disorders respectively. The severity of IBS symptoms was of minor clinical importance.

Conclusions

To help patients with IBS and reduced QoL, treatment should focus on QoL and not on relief of IBS symptoms. The different causes of reduced physical and mental QoL make an individually directed treatment necessary.

【 授权许可】

   
2015 Michalsen et al.

【 预 览 】
附件列表
Files Size Format View
20150912125759351.pdf 827KB PDF download
Fig. 3. 23KB Image download
Fig. 2. 22KB Image download
Fig. 1. 52KB Image download
【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】
  • [1]Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol. 2006; 41:650-6.
  • [2]Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012; 10:712-21.
  • [3]Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther. 2004; 20:1195-203.
  • [4]Lackner JM, Ma CX, Keefer L, Brenner DM, Gudleski GD, Satchidanand N et al.. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013; 11:1147-57.
  • [5]Amouretti M, Le PC, Gaudin AF, Bommelaer G, Frexinos J, Ruszniewski P et al.. Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterol Clin Biol. 2006; 30:241-6.
  • [6]Brun-Strang C, Dapoigny M, Lafuma A, Wainsten JP, Fagnani F. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study. Eur J Gastroenterol Hepatol. 2007; 19:1097-103.
  • [7]Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014; 40:1023-34.
  • [8]Johansson PA, Farup PG, Bracco A, Vandvik PO. How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice. BMC Gastroenterol. 2010; 10:31. BioMed Central Full Text
  • [9]Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther. 1997; 11:553-9.
  • [10]Coffin B, Dapoigny M, Cloarec D, Comet D, Dyard F. Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome. Gastroenterol Clin Biol. 2004; 28:11-5.
  • [11]Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014; 20:6759-73.
  • [12]Hungin AP, Molloy-Bland M, Claes R, Heidelbaugh J, Cayley WE, Muris J et al.. Systematic review: the perceptions, diagnosis and management of irritable bowel syndrome in primary care - A Rome Foundation Working Team Report. Aliment Pharmacol Ther. 2014; 40:1133-45.
  • [13]Ford AC, Vandvik PO. Irritable bowel syndrome. Clin Evid (Online ). 2012;2012.
  • [14]Rey E, Garcia-Alonso MO, Moreno-Ortega M, Alvarez-Sanchez A, Diaz-Rubio M. Determinants of quality of life in irritable bowel syndrome. J Clin Gastroenterol. 2008; 42:1003-9.
  • [15]Cho HS, Park JM, Lim CH, Cho YK, Lee IS, Kim SW et al.. Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver. 2011; 5:29-36.
  • [16]Spiegel BM, Gralnek IM, Bolus R, Chang L, Dulai GS, Mayer EA et al.. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med. 2004; 164:1773-80.
  • [17]Jamali R, Jamali A, Poorrahnama M, Omidi A, Jamali B, Moslemi N et al.. Evaluation of health related quality of life in irritable bowel syndrome patients. Health Qual Life Outcomes. 2012; 10:12. BioMed Central Full Text
  • [18]Vandvik PO, Kristensen P, Aabakken L, Farup PG. Abdominal complaints in general practice. Diagnoses and characteristics of patients. Scand J Prim Health Care. 2004; 22:157-62.
  • [19]Vandvik PO, Aabakken L, Farup PG. Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria. Scand J Gastroenterol. 2004; 39:448-53.
  • [20]Farup PG, Vandvik PO, Aabakken L. How useful are the Rome II criteria for identification of upper gastrointestinal disorders in general practice? Scand J Gastroenterol. 2005; 40:1284-9.
  • [21]Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE et al.. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998; 51:1171-8.
  • [22]Ihlebaek C, Eriksen HR, Ursin H. Prevalence of subjective health complaints (SHC) in Norway. Scand J Public Health. 2002; 30:20-9.
  • [23]Strand BH, Dalgard OS, Tambs K, Rognerud M. Measuring the mental health status of the Norwegian population: A comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J Psychiatry. 2003; 57:113-8.
  • [24]Speckens AE, Spinhoven P, Sloekers PP, Bolk JH, Van Hemert AM. A validation study of the whitely index, the illness attitude scales, and the somatosensory amplification scale in general medical and general practice patients. J Psychosom Res. 1996; 40:95-104.
  • [25]Grayson DA. Latent trait analysis of the Eysenck personality questionnaire. J Psychiatr Res. 1986; 20:217-35.
  • [26]Sato T. The Eysenck personality questionnaire brief version: factor structure and reliability. J Psychol. 2005; 139:545-52.
  • [27]van Buuren S. Felxible imputation of missing data. Chapman & Hall /CRC Press, Taylor & Francis Group, 6000 Broken Sound Parkway NW, Boca Raton, FL, USA. 2012;49.
  • [28]Hillila MT, Siivola MT, Farkkila MA. Comorbidity and use of health-care services among irritable bowel syndrome sufferers. Scand J Gastroenterol. 2007; 42:799-806.
  • [29]Seres G, Kovacs Z, Kovacs A, Kerekgyarto O, Sardi K, Demeter P et al.. Different associations of health related quality of life with pain, psychological distress and coping strategies in patients with irritable bowel syndrome and inflammatory bowel disorder. J Clin Psychol Med Settings. 2008; 15:287-95.
  • [30]Lackner JM, Gudleski GD, Ma CX, Dewanwala A, Naliboff B. Fear of GI symptoms has an important impact on quality of life in patients with moderate-to-severe IBS. Am J Gastroenterol. 2014; 109:1815-23.
  • [31]Faresjo A, Grodzinsky E, Hallert C, Timpka T. Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary care. BMC Public Health. 2013; 13:832. BioMed Central Full Text
  • [32]Minocha A, Johnson WD, Abell TL, Wigington WC. Prevalence, sociodemography, and quality of life of older versus younger patients with irritable bowel syndrome: a population-based study. Dig Dis Sci. 2006; 51:446-53.
  • [33]Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997; 11:395-402.
  • [34]Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG et al.. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009; 338:b2393.
  文献评价指标  
  下载次数:0次 浏览次数:17次